메뉴 건너뛰기




Volumn 25, Issue 8, 2015, Pages 1201-1224

Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date

Author keywords

Cannabis; Dopamine; Dopamine receptor; Human; Neurotransmitter; Review

Indexed keywords

CANNABINOID; CANNABIS; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE; ENDOCANNABINOID; PSYCHOTROPIC AGENT;

EID: 84938743068     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.03.011     Document Type: Article
Times cited : (49)

References (95)
  • 2
    • 0000735519 scopus 로고
    • Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
    • Andréasson S., Allebeck P., Engström A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987, 2:1483-1486. 10.1016/S0140-6736(87)92620-1.
    • (1987) Lancet , vol.2 , pp. 1483-1486
    • Andréasson, S.1    Allebeck, P.2    Engström, A.3    Rydberg, U.4
  • 3
    • 0442307621 scopus 로고    scopus 로고
    • Causal association between cannabis andpsychosis: examinationof the evidence
    • Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis andpsychosis: examinationof the evidence. Br. J. Psychiatry 2004, 184:110-117. 10.1192/bjp.184.2.110.
    • (2004) Br. J. Psychiatry , vol.184 , pp. 110-117
    • Arseneault, L.1    Cannon, M.2    Witton, J.3    Murray, R.M.4
  • 4
    • 0016699656 scopus 로고
    • Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes
    • Banerjee S.P., Snyder S.H., Mechoulam R. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. J. Pharmacol. Exp. Ther. 1975, 194:74-81.
    • (1975) J. Pharmacol. Exp. Ther. , vol.194 , pp. 74-81
    • Banerjee, S.P.1    Snyder, S.H.2    Mechoulam, R.3
  • 5
    • 0034748234 scopus 로고    scopus 로고
    • The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders
    • Bannon M.J., Michelhaugh S.K., Wang J., Sacchetti P. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur. Neuropsychopharmacol. 2001, 11:449-455.
    • (2001) Eur. Neuropsychopharmacol. , vol.11 , pp. 449-455
    • Bannon, M.J.1    Michelhaugh, S.K.2    Wang, J.3    Sacchetti, P.4
  • 8
    • 79961220783 scopus 로고    scopus 로고
    • Adding tobacco to cannabis-its frequency and likely implications
    • Bélanger R.E., Akre C., Kuntsche E., Gmel G., Suris J.C. Adding tobacco to cannabis-its frequency and likely implications. Nicotine Tob. Res. 2011, 13:746-750. 10.1093/ntr/ntr043.
    • (2011) Nicotine Tob. Res. , vol.13 , pp. 746-750
    • Bélanger, R.E.1    Akre, C.2    Kuntsche, E.3    Gmel, G.4    Suris, J.C.5
  • 9
    • 84870053882 scopus 로고    scopus 로고
    • Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function
    • Bhattacharyya S., Atakan Z., Martin-Santos R., Crippa J.a, Kambeitz J., Prata D., Williams S., Brammer M., Collier D.a, McGuire P.K. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function. Mol. Psychiatry 2012, 17:1152-1155. 10.1038/mp.2011.187.
    • (2012) Mol. Psychiatry , vol.17 , pp. 1152-1155
    • Bhattacharyya, S.1    Atakan, Z.2    Martin-Santos, R.3    Crippa, J.A.4    Kambeitz, J.5    Prata, D.6    Williams, S.7    Brammer, M.8    Collier, D.A.9    McGuire, P.K.10
  • 13
    • 0018091004 scopus 로고
    • The effects of cannabinoids on body temperature and brain catecholamine synthesis
    • Bloom A.S., Johnson K.M., Dewey W.L. The effects of cannabinoids on body temperature and brain catecholamine synthesis. Res. Commun. Chem. Pathol. Pharmacol. 1978, 20:51-57.
    • (1978) Res. Commun. Chem. Pathol. Pharmacol. , vol.20 , pp. 51-57
    • Bloom, A.S.1    Johnson, K.M.2    Dewey, W.L.3
  • 14
    • 84894479797 scopus 로고    scopus 로고
    • Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms
    • Bloomfield M.A.P., Morgan C.J.A., Egerton A., Kapur S., Curran H.V., Howes O.D. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol. Psychiatry 2014, 75:470-478. 10.1016/j.biopsych.2013.05.027.
    • (2014) Biol. Psychiatry , vol.75 , pp. 470-478
    • Bloomfield, M.A.P.1    Morgan, C.J.A.2    Egerton, A.3    Kapur, S.4    Curran, H.V.5    Howes, O.D.6
  • 15
    • 84900854828 scopus 로고    scopus 로고
    • The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study
    • Bloomfield M.A.P., Morgan C.J.A., Kapur S., Curran H.V., Howes O.D. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. Psychopharmacology 2014, 231:2251-2259. 10.1007/s00213-014-3523-4.
    • (2014) Psychopharmacology , vol.231 , pp. 2251-2259
    • Bloomfield, M.A.P.1    Morgan, C.J.A.2    Kapur, S.3    Curran, H.V.4    Howes, O.D.5
  • 17
    • 35748974202 scopus 로고    scopus 로고
    • Elevated plasma dopamine metabolites in cannabis psychosis
    • Bowers M.B., Kantrowitz J.T. Elevated plasma dopamine metabolites in cannabis psychosis. Am. J. Psychiatry 2007, 10.1176/appi.ajp.2007.07010217.
    • (2007) Am. J. Psychiatry
    • Bowers, M.B.1    Kantrowitz, J.T.2
  • 19
    • 0034706069 scopus 로고    scopus 로고
    • Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study
    • Cheer J.F., Marsden C.A., Kendall D.A., Mason R. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience 2000, 99:661-667. 10.1016/S0306-4522(00)00241-4.
    • (2000) Neuroscience , vol.99 , pp. 661-667
    • Cheer, J.F.1    Marsden, C.A.2    Kendall, D.A.3    Mason, R.4
  • 20
    • 2342668029 scopus 로고    scopus 로고
    • Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats
    • Cheer J.F., Wassum K.M., Heien M.L.A.V, Phillips P.E.M., Wightman R.M. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J. Neurosci. 2004, 24:4393-4400. 10.1523/JNEUROSCI.0529-04.2004.
    • (2004) J. Neurosci. , vol.24 , pp. 4393-4400
    • Cheer, J.F.1    Wassum, K.M.2    Heien, M.L.A.V.3    Phillips, P.E.M.4    Wightman, R.M.5
  • 21
    • 0025161255 scopus 로고
    • δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis
    • Chen J., Paredes W., Li J., Smith D., Lowinson J., Gardner E.L. δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 1990, 102:156-162. 10.1007/BF02245916.
    • (1990) Psychopharmacology , vol.102 , pp. 156-162
    • Chen, J.1    Paredes, W.2    Li, J.3    Smith, D.4    Lowinson, J.5    Gardner, E.L.6
  • 25
    • 84889080215 scopus 로고    scopus 로고
    • Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions
    • Davis G.P., Compton M.T., Wang S., Levin F.R., Blanco C. Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr. Res. 2013, 151:197-202. 10.1016/j.schres.2013.10.018.
    • (2013) Schizophr. Res. , vol.151 , pp. 197-202
    • Davis, G.P.1    Compton, M.T.2    Wang, S.3    Levin, F.R.4    Blanco, C.5
  • 26
    • 0026070134 scopus 로고
    • Dopamine in schizophrenia: a review and reconceptualization
    • doi:1681750
    • Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 1991, 148:1474-1486. doi:1681750.
    • (1991) Am. J. Psychiatry , vol.148 , pp. 1474-1486
    • Davis, K.L.1    Kahn, R.S.2    Ko, G.3    Davidson, M.4
  • 27
    • 0037382707 scopus 로고    scopus 로고
    • Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia
    • Dean B., Bradbury R., Copolov D.L. Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia. Biol. Psychiatry 2003, 53:585-592. 10.1016/S0006-3223(02)01545-7.
    • (2003) Biol. Psychiatry , vol.53 , pp. 585-592
    • Dean, B.1    Bradbury, R.2    Copolov, D.L.3
  • 31
    • 84906077179 scopus 로고    scopus 로고
    • Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity
    • Faure P., Tolu S., Valverde S., Naudé J. Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity. Neuroscience 2014, 10.1016/j.neuroscience.2014.05.040.
    • (2014) Neuroscience
    • Faure, P.1    Tolu, S.2    Valverde, S.3    Naudé, J.4
  • 32
    • 0030887785 scopus 로고    scopus 로고
    • Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
    • French E.D., Dillon K., Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 1997, 8:649-652. 10.1097/00001756-199702100-00014.
    • (1997) Neuroreport , vol.8 , pp. 649-652
    • French, E.D.1    Dillon, K.2    Wu, X.3
  • 33
    • 20444398090 scopus 로고    scopus 로고
    • Endocannabinoid signaling system and brain reward: emphasis on dopamine
    • Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 2005, 263-284. 10.1016/j.pbb.2005.01.032.
    • (2005) Pharmacol. Biochem. Behav. , pp. 263-284
    • Gardner, E.L.1
  • 35
    • 0030973808 scopus 로고    scopus 로고
    • Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices
    • Gifford A.N., Samiian L., Gatley S.J., Ashby C.R. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices. Eur. J. Pharmacol. 1997, 324:187-192.
    • (1997) Eur. J. Pharmacol. , vol.324 , pp. 187-192
    • Gifford, A.N.1    Samiian, L.2    Gatley, S.J.3    Ashby, C.R.4
  • 36
    • 33646078787 scopus 로고    scopus 로고
    • Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography
    • Ginovart N., Galineau L., Willeit M., Mizrahi R., Bloomfield P.M., Seeman P., Houle S., Kapur S., Wilson A.A. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. J. Neurochem. 2006, 97:1089-1103. 10.1111/j.1471-4159.2006.03840.x.
    • (2006) J. Neurochem. , vol.97 , pp. 1089-1103
    • Ginovart, N.1    Galineau, L.2    Willeit, M.3    Mizrahi, R.4    Bloomfield, P.M.5    Seeman, P.6    Houle, S.7    Kapur, S.8    Wilson, A.A.9
  • 37
    • 84866430898 scopus 로고    scopus 로고
    • Chronic δ9-tetrahydrocannabinol exposure induces a sensitization of dopamine D2/3 receptors in the mesoaccumbens and nigrostriatal systems
    • Ginovart N., Tournier B.B., Moulin-Sallanon M., Steimer T., Ibanez V., Millet P. Chronic δ9-tetrahydrocannabinol exposure induces a sensitization of dopamine D2/3 receptors in the mesoaccumbens and nigrostriatal systems. Neuropsychopharmacology 2012, 10.1038/npp.2012.91.
    • (2012) Neuropsychopharmacology
    • Ginovart, N.1    Tournier, B.B.2    Moulin-Sallanon, M.3    Steimer, T.4    Ibanez, V.5    Millet, P.6
  • 40
    • 33751119258 scopus 로고    scopus 로고
    • An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition
    • Henquet C., Rosa A., Krabbendam L., Papiol S., Fananás L., Drukker M., Ramaekers J.G., van Os J. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006, 31:2748-2757. 10.1038/sj.npp.1301197.
    • (2006) Neuropsychopharmacology , vol.31 , pp. 2748-2757
    • Henquet, C.1    Rosa, A.2    Krabbendam, L.3    Papiol, S.4    Fananás, L.5    Drukker, M.6    Ramaekers, J.G.7    van Os, J.8
  • 41
    • 13244256818 scopus 로고    scopus 로고
    • Cerebrovascular perfusion in marijuana users during a month of monitored abstinence
    • Herning R.I., Better W.E., Tate K., Cadet J.L Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology 2005, 64:488-493. 10.1212/WNL.65.7.1145.
    • (2005) Neurology , vol.64 , pp. 488-493
    • Herning, R.I.1    Better, W.E.2    Tate, K.3    Cadet, J.L.4
  • 43
    • 65349120160 scopus 로고    scopus 로고
    • The dopamine hypothesis of schizophrenia: version III-the final common pathway
    • Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 2009, 35:549-562. 10.1093/schbul/sbp006.
    • (2009) Schizophr. Bull. , vol.35 , pp. 549-562
    • Howes, O.D.1    Kapur, S.2
  • 44
    • 34548510337 scopus 로고    scopus 로고
    • Human cannabinoid pharmacokinetics
    • Huestis M.A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 2007, 10.1002/cbdv.200790152.
    • (2007) Chem. Biodivers.
    • Huestis, M.A.1
  • 45
    • 0032590232 scopus 로고    scopus 로고
    • CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide
    • Kathmann M., Bauer U., Schlicker E. CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide. Naunyn. Schmiedebergs. Arch. Pharmacol. 1999, 360:421-427. 10.1007/s002109900091.
    • (1999) Naunyn. Schmiedebergs. Arch. Pharmacol. , vol.360 , pp. 421-427
    • Kathmann, M.1    Bauer, U.2    Schlicker, E.3
  • 48
    • 77955054913 scopus 로고    scopus 로고
    • Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
    • Kuepper R., Morrison P.D., van Os J., Murray R.M., Kenis G., Henquet C. Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr. Res. 2010, 10.1016/j.schres.2010.05.031.
    • (2010) Schizophr. Res.
    • Kuepper, R.1    Morrison, P.D.2    van Os, J.3    Murray, R.M.4    Kenis, G.5    Henquet, C.6
  • 51
    • 0036897933 scopus 로고    scopus 로고
    • Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men
    • Leyton M., Boileau I., Benkelfat C., Diksic M., Baker G., Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 2002, 27:1027-1035. 10.1016/S0893-133X(02)00366-4.
    • (2002) Neuropsychopharmacology , vol.27 , pp. 1027-1035
    • Leyton, M.1    Boileau, I.2    Benkelfat, C.3    Diksic, M.4    Baker, G.5    Dagher, A.6
  • 53
    • 4744351585 scopus 로고    scopus 로고
    • Marijuana and cannabinoid regulation of brain reward circuits
    • Lupica C.R., Riegel A.C., Hoffman A.F. Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 2004, 143:227-234. 10.1038/sj.bjp.0705931.
    • (2004) Br. J. Pharmacol. , vol.143 , pp. 227-234
    • Lupica, C.R.1    Riegel, A.C.2    Hoffman, A.F.3
  • 55
    • 0019958135 scopus 로고
    • Effects of acute cannabis use and short-term deprivation on plasma prolactin and dopamine-beta-hydroxylase in long-term users
    • Markianos M., Stefanis C. Effects of acute cannabis use and short-term deprivation on plasma prolactin and dopamine-beta-hydroxylase in long-term users. Drug Alcohol Depend. 1982, 9:251-255. 10.1016/0376-8716(82)90050-3.
    • (1982) Drug Alcohol Depend. , vol.9 , pp. 251-255
    • Markianos, M.1    Stefanis, C.2
  • 56
    • 0021691720 scopus 로고
    • Effects of acute cannabis use on urinary neurotransmitter metabolites and cyclic nucleotides in man
    • Markianos M., Vakis A. Effects of acute cannabis use on urinary neurotransmitter metabolites and cyclic nucleotides in man. Drug Alcohol Depend. 1984, 14:175-178. 10.1016/0376-8716(84)90042-5.
    • (1984) Drug Alcohol Depend. , vol.14 , pp. 175-178
    • Markianos, M.1    Vakis, A.2
  • 57
    • 0015839227 scopus 로고
    • Effect of cannabis sativa administered by smoking on biogenic amine excretion in man
    • Messiha F.S., Soskin R.A. Effect of cannabis sativa administered by smoking on biogenic amine excretion in man. Res. Commun. Chem. Pathol. Pharmacol. 1973, 6:325-328.
    • (1973) Res. Commun. Chem. Pathol. Pharmacol. , vol.6 , pp. 325-328
    • Messiha, F.S.1    Soskin, R.A.2
  • 58
  • 59
    • 84873739013 scopus 로고    scopus 로고
    • Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-±PHNO
    • Mizrahi R., Suridjan I., Kenk M., George T.P., Wilson A., Houle S., Rusjan P. Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-±PHNO. Neuropsychopharmacology 2013, 38:673-682. 10.1038/npp.2012.232.
    • (2013) Neuropsychopharmacology , vol.38 , pp. 673-682
    • Mizrahi, R.1    Suridjan, I.2    Kenk, M.3    George, T.P.4    Wilson, A.5    Houle, S.6    Rusjan, P.7
  • 60
    • 34447619511 scopus 로고    scopus 로고
    • Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
    • Moore T.H.M., Zammit S., Lingford-Hughes A., Barnes T.R.E., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328. 10.1016/S0140-6736(07)61162-3.
    • (2007) Lancet , vol.370 , pp. 319-328
    • Moore, T.H.M.1    Zammit, S.2    Lingford-Hughes, A.3    Barnes, T.R.E.4    Jones, P.B.5    Burke, M.6    Lewis, G.7
  • 63
    • 0029064115 scopus 로고
    • Relationships between motivation and depression in chronic marijuana users
    • Musty R.E., Kaback L. Relationships between motivation and depression in chronic marijuana users. Life Sci. 1995, 2151-2158. 10.1016/0024-3205(95)00202-H.
    • (1995) Life Sci. , pp. 2151-2158
    • Musty, R.E.1    Kaback, L.2
  • 64
    • 77951088919 scopus 로고    scopus 로고
    • A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum
    • Narendran R., Mason N.S., Laymon C.M., Lopresti B.J., Velasquez N.D., May M.A., Kendro S., Martinez D., Mathis C.A., Frankle W.G. A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum. J. Pharmacol. Exp. Ther. 2010, 333:533-539. 10.1124/jpet.109.163501.
    • (2010) J. Pharmacol. Exp. Ther. , vol.333 , pp. 533-539
    • Narendran, R.1    Mason, N.S.2    Laymon, C.M.3    Lopresti, B.J.4    Velasquez, N.D.5    May, M.A.6    Kendro, S.7    Martinez, D.8    Mathis, C.A.9    Frankle, W.G.10
  • 66
    • 21344456178 scopus 로고    scopus 로고
    • Chronic drug exposures during development in nonhuman primates: models of brain dysfunction in humans
    • Paule M.G. Chronic drug exposures during development in nonhuman primates: models of brain dysfunction in humans. Front. Biosci. 2005, 10:2240-2249. 10.2741/1693.
    • (2005) Front. Biosci. , vol.10 , pp. 2240-2249
    • Paule, M.G.1
  • 68
    • 29244432491 scopus 로고    scopus 로고
    • The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    • Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 2006, 10.1016/j.neubiorev.2005.04.016.
    • (2006) Neurosci. Biobehav. Rev.
    • Pierce, R.C.1    Kumaresan, V.2
  • 69
    • 0036460442 scopus 로고    scopus 로고
    • Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study
    • Pistis M., Muntoni A.L., Pillolla G., Gessa G.L. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur. J. Neurosci. 2002, 15:1795-1802. 10.1046/j.1460-9568.2002.02019.x.
    • (2002) Eur. J. Neurosci. , vol.15 , pp. 1795-1802
    • Pistis, M.1    Muntoni, A.L.2    Pillolla, G.3    Gessa, G.L.4
  • 70
    • 0034904322 scopus 로고    scopus 로고
    • Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation
    • Pistis M., Porcu G., Melis M., Diana M., Gessa G.L. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. Eur. J. Neurosci. 2001, 14:96-102. 10.1046/j.0953-816X.2001.01612.x.
    • (2001) Eur. J. Neurosci. , vol.14 , pp. 96-102
    • Pistis, M.1    Porcu, G.2    Melis, M.3    Diana, M.4    Gessa, G.L.5
  • 71
    • 0018954391 scopus 로고
    • Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes
    • Poddar M.K., Dewey W.L. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. J. Pharmacol. Exp. Ther. 1980, 214:63-67.
    • (1980) J. Pharmacol. Exp. Ther. , vol.214 , pp. 63-67
    • Poddar, M.K.1    Dewey, W.L.2
  • 75
    • 0030608801 scopus 로고    scopus 로고
    • Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus
    • Schlicker E., Timm J., Zentner J., Göthert M. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn. Schmiedebergs. Arch. Pharmacol. 1997, 356:583-589. 10.1007/PL00005093.
    • (1997) Naunyn. Schmiedebergs. Arch. Pharmacol. , vol.356 , pp. 583-589
    • Schlicker, E.1    Timm, J.2    Zentner, J.3    Göthert, M.4
  • 76
    • 41849112002 scopus 로고    scopus 로고
    • Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography
    • Sevy S., Smith G.S., Ma Y., Dhawan V., Chaly T., Kingsley P.B., Kumra S., Abdelmessih S., Eidelberg D. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology 2008, 197:549-556. 10.1007/s00213-008-1075-1.
    • (2008) Psychopharmacology , vol.197 , pp. 549-556
    • Sevy, S.1    Smith, G.S.2    Ma, Y.3    Dhawan, V.4    Chaly, T.5    Kingsley, P.B.6    Kumra, S.7    Abdelmessih, S.8    Eidelberg, D.9
  • 78
    • 0017277759 scopus 로고
    • The dopamine hypothesis of schizophrenia: focus on the dopamine receptor
    • Snyder S.H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am. J. Psychiatry 1976, 133:197-202. 10.1093/schbul/2.1.19.
    • (1976) Am. J. Psychiatry , vol.133 , pp. 197-202
    • Snyder, S.H.1
  • 79
    • 2342632473 scopus 로고    scopus 로고
    • Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex
    • Steffens M., Engler C., Zentner J., Feuerstein T.J. Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. Br. J. Pharmacol. 2004, 141:1193-1203. 10.1038/sj.bjp.0705706.
    • (2004) Br. J. Pharmacol. , vol.141 , pp. 1193-1203
    • Steffens, M.1    Engler, C.2    Zentner, J.3    Feuerstein, T.J.4
  • 82
    • 67949121758 scopus 로고    scopus 로고
    • Can recreational doses of THC produce significant dopamine release in the human striatum?
    • Stokes P.R.A., Mehta M.A., Curran H.V., Breen G., Grasby P.M. Can recreational doses of THC produce significant dopamine release in the human striatum?. Neuroimage 2009, 48:186-190. 10.1016/j.neuroimage.2009.06.029.
    • (2009) Neuroimage , vol.48 , pp. 186-190
    • Stokes, P.R.A.1    Mehta, M.A.2    Curran, H.V.3    Breen, G.4    Grasby, P.M.5
  • 83
    • 0141451977 scopus 로고    scopus 로고
    • Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data
    • Tanda, G., Goldberg, S.R., 2003. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology. 10.1007/s00213-003-1485-z.
    • (2003) Psychopharmacology
    • Tanda, G.1    Goldberg, S.R.2
  • 84
    • 0030761521 scopus 로고    scopus 로고
    • Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
    • Tanda G., Pontieri F.E., Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997, 276:2048-2050. 10.1126/science.276.5321.2048.
    • (1997) Science , vol.276 , pp. 2048-2050
    • Tanda, G.1    Pontieri, F.E.2    Di Chiara, G.3
  • 85
    • 84890551498 scopus 로고    scopus 로고
    • World Drug Report 2013. Joost 2013.
    • United Nations Office on Drugs and Crime, 2013. World Drug Report 2013. Joost 2013, 316. doi:10.1002/yd.20002.
    • (2013) , pp. 316
  • 87
    • 45849099117 scopus 로고    scopus 로고
    • Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial
    • Van Nimwegen L.J., de Haan L., van Beveren N.J., van der Helm M., van den Brink W., Linszen D. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Can. J. Psychiatry 2008, 53:400-405.
    • (2008) Can. J. Psychiatry , vol.53 , pp. 400-405
    • Van Nimwegen, L.J.1    de Haan, L.2    van Beveren, N.J.3    van der Helm, M.4    van den Brink, W.5    Linszen, D.6
  • 88
    • 79951472497 scopus 로고    scopus 로고
    • Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up
    • Van Winkel R. Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch. Gen. Psychiatry 2011, 68:148-157. 10.1001/archgenpsychiatry.2010.152.
    • (2011) Arch. Gen. Psychiatry , vol.68 , pp. 148-157
    • Van Winkel, R.1
  • 89
    • 84897446932 scopus 로고    scopus 로고
    • Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis
    • Van Winkel R., Kuepper R. Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis. Annu. Rev. Clin. Psychol. 2014, 10:767-791. 10.1146/annurev-clinpsy-032813-153631.
    • (2014) Annu. Rev. Clin. Psychol. , vol.10 , pp. 767-791
    • Van Winkel, R.1    Kuepper, R.2
  • 90
    • 84885857705 scopus 로고    scopus 로고
    • A longitudinal analysis of the effects of a DRD4 polymorphism on marijuana use
    • Vaske J., Boisvert D., Wright J.P., Beaver K.M. A longitudinal analysis of the effects of a DRD4 polymorphism on marijuana use. Psychiatry Res. 2013, 210:247-255. 10.1016/j.psychres.2013.04.022.
    • (2013) Psychiatry Res. , vol.210 , pp. 247-255
    • Vaske, J.1    Boisvert, D.2    Wright, J.P.3    Beaver, K.M.4
  • 91
    • 84904962560 scopus 로고    scopus 로고
    • Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity
    • Volkow N.D., Wang G.-J., Telang F., Fowler J.S., Alexoff D., Logan J., Jayne M., Wong C., Tomasi D. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc. Natl. Acad. Sci. 2014, 1411228111. 10.1073/pnas.1411228111.
    • (2014) Proc. Natl. Acad. Sci. , pp. 1411228111
    • Volkow, N.D.1    Wang, G.-J.2    Telang, F.3    Fowler, J.S.4    Alexoff, D.5    Logan, J.6    Jayne, M.7    Wong, C.8    Tomasi, D.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.